Trial NCT00975767

View at ClinicalTrials.gov 
Org. Study IDs: 265-103

Last trial update was posted on 2015-01-08

MeSH Interventions

Docetaxel Erlotinib Hydrochloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms Neoplasms

Other Conditions

Advanced Malignancies, Non-small Cell Lung Cancer

Stopping Reasons

The study was terminated due to a need for a reformulation of the study drug. Phase 1 completed, no patients enrolled in Phase 2.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID